REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/29/2026
Back to search
Official data from USPTO
LIVERDX FORMULA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/29/2026
Trademark type
Combined
Nice classes
5
Filing date
01/27/2020
Registration date
06/29/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2021
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
98
Owner location
AT
Examiner
CHARLON, BARNEY
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LIVERDX FORMULA".
Holders and representatives
Holders
Biogena GmbH & Co KG
Biogena Naturprodukte GmbH & Co KG
Representatives
Jeff Goehring Nixon & Vanderhye P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparationsnutraceuticals for use as a dietary supplement; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary usein particular dietetic products for a balanced diet for medical or veterinary use; starch for medical dietetic food or pharmaceutical purposes; food for babiesin particular powdered milk for babies; dietary supplements for humans and animals for medical purposesin particular antioxidants for humans and animals for medical purposes; nutritional supplements and dietetic food supplements for sports and performance enhancement adapted for medical use; meal replacement powders for sports and performance enhancement for medical use; mineral food supplementsconsisting primarily of vitaminsamino acidsminerals and trace elementsadapted for medical purposes; vitamin preparations; preparations for making medicated dietetic beverages; drinks for medical purposesin particular herbal teas for medicinal purposes; medical plasters; surgical dressings; material for dental fillings and dental impressions; disinfectants; preparations for destroying noxious animals; fungicidesherbicides
Publications
History of USPTO decisions and trademark events.
31 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/15/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/15/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/22/2021
FIMP
FINAL DISPOSITION PROCESSED
10/21/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/13/2021
PUBO
PUBLISHED FOR OPPOSITION
04/13/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2021
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
12/29/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2020
RFNT
REFUSAL PROCESSED BY IB
07/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/07/2020
RFRR
REFUSAL PROCESSED BY MPU
07/07/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/05/2020
CNRT
NON-FINAL ACTION WRITTEN
06/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/02/2020
DOCK
ASSIGNED TO EXAMINER
05/29/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/29/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/28/2020
Continuous trademark protection
Get notified about every new filing that threatens LIVERDX FORMULA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.